Hodgkin’s lymphoma: 2023 update on treatment
Main Authors: | Sicong Zhang, Xianming Liu, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Xianhuo Wang, Huilai Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2024-04-01
|
Series: | Cancer Biology & Medicine |
Online Access: | https://www.cancerbiomed.org/content/21/4/269 |
Similar Items
-
Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer
by: Peiqi Zhao, et al.
Published: (2021-06-01) -
Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China
by: Fenghua Gao, et al.
Published: (2022-09-01) -
m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment
by: Tingting Zhang, et al.
Published: (2022-06-01) -
PIM1 genetic alterations associated with distinct molecular profiles, phenotypes and drug responses in diffuse large B‐cell lymphoma
by: Huilai Zhang, et al.
Published: (2022-04-01) -
A retrospective analysis of mature T- and NK-cell lymphomas
by: Junlei Jia, et al.
Published: (2024-03-01)